nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofazimine—ABCB1—ovarian cancer	0.385	1	CbGaD
Clofazimine—ABCB11—Paclitaxel—ovarian cancer	0.166	0.322	CbGbCtD
Clofazimine—ABCB11—Doxorubicin—ovarian cancer	0.0896	0.174	CbGbCtD
Clofazimine—ABCB1—Topotecan—ovarian cancer	0.0576	0.112	CbGbCtD
Clofazimine—ABCB1—Vinorelbine—ovarian cancer	0.0406	0.0786	CbGbCtD
Clofazimine—CYP3A4—Topotecan—ovarian cancer	0.0345	0.0669	CbGbCtD
Clofazimine—ABCB1—Paclitaxel—ovarian cancer	0.0285	0.0552	CbGbCtD
Clofazimine—CYP3A4—Vinorelbine—ovarian cancer	0.0243	0.0471	CbGbCtD
Clofazimine—ABCB1—Docetaxel—ovarian cancer	0.0206	0.0399	CbGbCtD
Clofazimine—CYP3A4—Paclitaxel—ovarian cancer	0.0171	0.0331	CbGbCtD
Clofazimine—ABCB1—Doxorubicin—ovarian cancer	0.0154	0.0298	CbGbCtD
Clofazimine—CYP3A4—Docetaxel—ovarian cancer	0.0123	0.0239	CbGbCtD
Clofazimine—CYP3A4—Doxorubicin—ovarian cancer	0.00921	0.0178	CbGbCtD
Clofazimine—Intestinal obstruction—Topotecan—ovarian cancer	0.00196	0.0198	CcSEcCtD
Clofazimine—Neuralgia—Topotecan—ovarian cancer	0.00192	0.0195	CcSEcCtD
Clofazimine—Enteritis—Docetaxel—ovarian cancer	0.00191	0.0193	CcSEcCtD
Clofazimine—Embolism—Vinorelbine—ovarian cancer	0.00178	0.018	CcSEcCtD
Clofazimine—Anaemia—Altretamine—ovarian cancer	0.00171	0.0173	CcSEcCtD
Clofazimine—Intestinal obstruction—Vinorelbine—ovarian cancer	0.00168	0.017	CcSEcCtD
Clofazimine—Cystitis noninfective—Chlorambucil—ovarian cancer	0.00147	0.0148	CcSEcCtD
Clofazimine—Cystitis—Chlorambucil—ovarian cancer	0.00145	0.0147	CcSEcCtD
Clofazimine—Anorexia—Altretamine—ovarian cancer	0.00144	0.0145	CcSEcCtD
Clofazimine—Bone pain—Topotecan—ovarian cancer	0.0014	0.0141	CcSEcCtD
Clofazimine—Thromboembolism—Epirubicin—ovarian cancer	0.00138	0.014	CcSEcCtD
Clofazimine—Bladder pain—Chlorambucil—ovarian cancer	0.00136	0.0137	CcSEcCtD
Clofazimine—Decreased appetite—Altretamine—ovarian cancer	0.00131	0.0133	CcSEcCtD
Clofazimine—Fatigue—Altretamine—ovarian cancer	0.0013	0.0131	CcSEcCtD
Clofazimine—Visual acuity reduced—Paclitaxel—ovarian cancer	0.00129	0.0131	CcSEcCtD
Clofazimine—Thromboembolism—Doxorubicin—ovarian cancer	0.00128	0.0129	CcSEcCtD
Clofazimine—Cystitis noninfective—Melphalan—ovarian cancer	0.00128	0.0129	CcSEcCtD
Clofazimine—Lymphadenopathy—Chlorambucil—ovarian cancer	0.00128	0.0129	CcSEcCtD
Clofazimine—Cystitis—Melphalan—ovarian cancer	0.00126	0.0128	CcSEcCtD
Clofazimine—Embolism—Paclitaxel—ovarian cancer	0.0012	0.0121	CcSEcCtD
Clofazimine—Bladder pain—Melphalan—ovarian cancer	0.00118	0.012	CcSEcCtD
Clofazimine—Intestinal obstruction—Paclitaxel—ovarian cancer	0.00113	0.0114	CcSEcCtD
Clofazimine—Neuralgia—Paclitaxel—ovarian cancer	0.00111	0.0112	CcSEcCtD
Clofazimine—Hepatomegaly—Paclitaxel—ovarian cancer	0.00109	0.011	CcSEcCtD
Clofazimine—Asthenia—Altretamine—ovarian cancer	0.00108	0.0109	CcSEcCtD
Clofazimine—Embolism—Docetaxel—ovarian cancer	0.00102	0.0103	CcSEcCtD
Clofazimine—Dizziness—Altretamine—ovarian cancer	0.000997	0.0101	CcSEcCtD
Clofazimine—Vomiting—Altretamine—ovarian cancer	0.000958	0.00969	CcSEcCtD
Clofazimine—Intestinal obstruction—Docetaxel—ovarian cancer	0.000956	0.00967	CcSEcCtD
Clofazimine—Neuralgia—Docetaxel—ovarian cancer	0.000938	0.00949	CcSEcCtD
Clofazimine—Nausea—Altretamine—ovarian cancer	0.000895	0.00906	CcSEcCtD
Clofazimine—Embolism venous—Epirubicin—ovarian cancer	0.000871	0.00881	CcSEcCtD
Clofazimine—Skin discolouration—Paclitaxel—ovarian cancer	0.000852	0.00861	CcSEcCtD
Clofazimine—Body temperature increased—Carboplatin—ovarian cancer	0.000823	0.00833	CcSEcCtD
Clofazimine—Jaundice—Chlorambucil—ovarian cancer	0.000819	0.00828	CcSEcCtD
Clofazimine—Embolism venous—Doxorubicin—ovarian cancer	0.000806	0.00815	CcSEcCtD
Clofazimine—Bone pain—Paclitaxel—ovarian cancer	0.000803	0.00812	CcSEcCtD
Clofazimine—Jaundice—Melphalan—ovarian cancer	0.000714	0.00722	CcSEcCtD
Clofazimine—Embolism—Epirubicin—ovarian cancer	0.000685	0.00693	CcSEcCtD
Clofazimine—Bone pain—Docetaxel—ovarian cancer	0.000681	0.00688	CcSEcCtD
Clofazimine—Hepatitis—Melphalan—ovarian cancer	0.000657	0.00665	CcSEcCtD
Clofazimine—Weight decreased—Vinorelbine—ovarian cancer	0.000649	0.00656	CcSEcCtD
Clofazimine—Embolism—Doxorubicin—ovarian cancer	0.000634	0.00641	CcSEcCtD
Clofazimine—Neuralgia—Epirubicin—ovarian cancer	0.000633	0.0064	CcSEcCtD
Clofazimine—Hepatomegaly—Epirubicin—ovarian cancer	0.000621	0.00628	CcSEcCtD
Clofazimine—Anaemia—Chlorambucil—ovarian cancer	0.000607	0.00614	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.000592	0.00598	CcSEcCtD
Clofazimine—Neuralgia—Doxorubicin—ovarian cancer	0.000586	0.00592	CcSEcCtD
Clofazimine—Hepatomegaly—Doxorubicin—ovarian cancer	0.000575	0.00581	CcSEcCtD
Clofazimine—Anaemia—Topotecan—ovarian cancer	0.00054	0.00546	CcSEcCtD
Clofazimine—Anaemia—Melphalan—ovarian cancer	0.000529	0.00535	CcSEcCtD
Clofazimine—Anorexia—Chlorambucil—ovarian cancer	0.000511	0.00516	CcSEcCtD
Clofazimine—Abdominal pain upper—Paclitaxel—ovarian cancer	0.00051	0.00516	CcSEcCtD
Clofazimine—Hypokalaemia—Paclitaxel—ovarian cancer	0.000508	0.00514	CcSEcCtD
Clofazimine—Skin discolouration—Epirubicin—ovarian cancer	0.000487	0.00492	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.000473	0.00479	CcSEcCtD
Clofazimine—Oedema—Melphalan—ovarian cancer	0.000467	0.00472	CcSEcCtD
Clofazimine—Decreased appetite—Chlorambucil—ovarian cancer	0.000466	0.00471	CcSEcCtD
Clofazimine—Anaemia—Vinorelbine—ovarian cancer	0.000462	0.00467	CcSEcCtD
Clofazimine—Fatigue—Chlorambucil—ovarian cancer	0.000462	0.00467	CcSEcCtD
Clofazimine—Bone pain—Epirubicin—ovarian cancer	0.000459	0.00464	CcSEcCtD
Clofazimine—Anorexia—Topotecan—ovarian cancer	0.000455	0.0046	CcSEcCtD
Clofazimine—Skin discolouration—Doxorubicin—ovarian cancer	0.00045	0.00456	CcSEcCtD
Clofazimine—Anorexia—Melphalan—ovarian cancer	0.000445	0.0045	CcSEcCtD
Clofazimine—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.00044	0.00445	CcSEcCtD
Clofazimine—Weight decreased—Paclitaxel—ovarian cancer	0.000437	0.00442	CcSEcCtD
Clofazimine—Hyperglycaemia—Paclitaxel—ovarian cancer	0.000435	0.0044	CcSEcCtD
Clofazimine—Abdominal pain upper—Docetaxel—ovarian cancer	0.000432	0.00437	CcSEcCtD
Clofazimine—Cystitis noninfective—Epirubicin—ovarian cancer	0.00043	0.00434	CcSEcCtD
Clofazimine—Depression—Paclitaxel—ovarian cancer	0.000429	0.00434	CcSEcCtD
Clofazimine—Bone pain—Doxorubicin—ovarian cancer	0.000425	0.0043	CcSEcCtD
Clofazimine—Cystitis—Epirubicin—ovarian cancer	0.000425	0.00429	CcSEcCtD
Clofazimine—Body temperature increased—Chlorambucil—ovarian cancer	0.000424	0.00428	CcSEcCtD
Clofazimine—Decreased appetite—Topotecan—ovarian cancer	0.000415	0.00419	CcSEcCtD
Clofazimine—Fatigue—Topotecan—ovarian cancer	0.000411	0.00416	CcSEcCtD
Clofazimine—Constipation—Topotecan—ovarian cancer	0.000408	0.00412	CcSEcCtD
Clofazimine—Decreased appetite—Melphalan—ovarian cancer	0.000406	0.00411	CcSEcCtD
Clofazimine—Fatigue—Melphalan—ovarian cancer	0.000403	0.00407	CcSEcCtD
Clofazimine—Bladder pain—Epirubicin—ovarian cancer	0.000398	0.00402	CcSEcCtD
Clofazimine—Cystitis noninfective—Doxorubicin—ovarian cancer	0.000397	0.00402	CcSEcCtD
Clofazimine—Cystitis—Doxorubicin—ovarian cancer	0.000393	0.00397	CcSEcCtD
Clofazimine—Anorexia—Vinorelbine—ovarian cancer	0.000389	0.00393	CcSEcCtD
Clofazimine—Asthenia—Chlorambucil—ovarian cancer	0.000384	0.00389	CcSEcCtD
Clofazimine—Pruritus—Chlorambucil—ovarian cancer	0.000379	0.00383	CcSEcCtD
Clofazimine—Body temperature increased—Topotecan—ovarian cancer	0.000377	0.00381	CcSEcCtD
Clofazimine—Lymphadenopathy—Epirubicin—ovarian cancer	0.000374	0.00378	CcSEcCtD
Clofazimine—Visual impairment—Paclitaxel—ovarian cancer	0.000372	0.00376	CcSEcCtD
Clofazimine—Weight decreased—Docetaxel—ovarian cancer	0.00037	0.00374	CcSEcCtD
Clofazimine—Bladder pain—Doxorubicin—ovarian cancer	0.000368	0.00372	CcSEcCtD
Clofazimine—Diarrhoea—Chlorambucil—ovarian cancer	0.000367	0.00371	CcSEcCtD
Clofazimine—Jaundice—Docetaxel—ovarian cancer	0.000355	0.0036	CcSEcCtD
Clofazimine—Decreased appetite—Vinorelbine—ovarian cancer	0.000355	0.00359	CcSEcCtD
Clofazimine—Fatigue—Vinorelbine—ovarian cancer	0.000352	0.00356	CcSEcCtD
Clofazimine—Constipation—Vinorelbine—ovarian cancer	0.000349	0.00353	CcSEcCtD
Clofazimine—Lymphadenopathy—Doxorubicin—ovarian cancer	0.000346	0.0035	CcSEcCtD
Clofazimine—Asthenia—Topotecan—ovarian cancer	0.000342	0.00346	CcSEcCtD
Clofazimine—Vomiting—Chlorambucil—ovarian cancer	0.000341	0.00344	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.000338	0.00342	CcSEcCtD
Clofazimine—Pruritus—Topotecan—ovarian cancer	0.000337	0.00341	CcSEcCtD
Clofazimine—Asthenia—Melphalan—ovarian cancer	0.000335	0.00339	CcSEcCtD
Clofazimine—Pruritus—Melphalan—ovarian cancer	0.00033	0.00334	CcSEcCtD
Clofazimine—Hepatitis—Docetaxel—ovarian cancer	0.000327	0.00331	CcSEcCtD
Clofazimine—Diarrhoea—Topotecan—ovarian cancer	0.000326	0.0033	CcSEcCtD
Clofazimine—Body temperature increased—Vinorelbine—ovarian cancer	0.000323	0.00326	CcSEcCtD
Clofazimine—Diarrhoea—Melphalan—ovarian cancer	0.00032	0.00323	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.000319	0.00323	CcSEcCtD
Clofazimine—Nausea—Chlorambucil—ovarian cancer	0.000318	0.00322	CcSEcCtD
Clofazimine—Visual impairment—Docetaxel—ovarian cancer	0.000316	0.00319	CcSEcCtD
Clofazimine—Dizziness—Topotecan—ovarian cancer	0.000315	0.00319	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000313	0.00317	CcSEcCtD
Clofazimine—Anaemia—Paclitaxel—ovarian cancer	0.000311	0.00314	CcSEcCtD
Clofazimine—Vomiting—Topotecan—ovarian cancer	0.000303	0.00307	CcSEcCtD
Clofazimine—Rash—Topotecan—ovarian cancer	0.000301	0.00304	CcSEcCtD
Clofazimine—Dermatitis—Topotecan—ovarian cancer	0.0003	0.00304	CcSEcCtD
Clofazimine—Headache—Topotecan—ovarian cancer	0.000299	0.00302	CcSEcCtD
Clofazimine—Vomiting—Melphalan—ovarian cancer	0.000297	0.003	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000295	0.00299	CcSEcCtD
Clofazimine—Rash—Melphalan—ovarian cancer	0.000294	0.00298	CcSEcCtD
Clofazimine—Dermatitis—Melphalan—ovarian cancer	0.000294	0.00298	CcSEcCtD
Clofazimine—Asthenia—Vinorelbine—ovarian cancer	0.000293	0.00296	CcSEcCtD
Clofazimine—Abdominal pain upper—Epirubicin—ovarian cancer	0.000292	0.00295	CcSEcCtD
Clofazimine—Hypokalaemia—Epirubicin—ovarian cancer	0.000291	0.00294	CcSEcCtD
Clofazimine—Pruritus—Vinorelbine—ovarian cancer	0.000289	0.00292	CcSEcCtD
Clofazimine—Nausea—Topotecan—ovarian cancer	0.000283	0.00287	CcSEcCtD
Clofazimine—Diarrhoea—Vinorelbine—ovarian cancer	0.000279	0.00282	CcSEcCtD
Clofazimine—Nausea—Melphalan—ovarian cancer	0.000277	0.00281	CcSEcCtD
Clofazimine—Oedema—Paclitaxel—ovarian cancer	0.000274	0.00278	CcSEcCtD
Clofazimine—Eosinophilia—Epirubicin—ovarian cancer	0.000273	0.00276	CcSEcCtD
Clofazimine—Dizziness—Vinorelbine—ovarian cancer	0.00027	0.00273	CcSEcCtD
Clofazimine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00027	0.00273	CcSEcCtD
Clofazimine—Hypokalaemia—Doxorubicin—ovarian cancer	0.000269	0.00272	CcSEcCtD
Clofazimine—Anaemia—Docetaxel—ovarian cancer	0.000263	0.00266	CcSEcCtD
Clofazimine—Anorexia—Paclitaxel—ovarian cancer	0.000262	0.00265	CcSEcCtD
Clofazimine—Vomiting—Vinorelbine—ovarian cancer	0.000259	0.00262	CcSEcCtD
Clofazimine—Rash—Vinorelbine—ovarian cancer	0.000257	0.0026	CcSEcCtD
Clofazimine—Dermatitis—Vinorelbine—ovarian cancer	0.000257	0.0026	CcSEcCtD
Clofazimine—Headache—Vinorelbine—ovarian cancer	0.000256	0.00258	CcSEcCtD
Clofazimine—Eosinophilia—Doxorubicin—ovarian cancer	0.000253	0.00256	CcSEcCtD
Clofazimine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000252	0.00255	CcSEcCtD
Clofazimine—Weight decreased—Epirubicin—ovarian cancer	0.00025	0.00252	CcSEcCtD
Clofazimine—Hyperglycaemia—Epirubicin—ovarian cancer	0.000249	0.00252	CcSEcCtD
Clofazimine—Drowsiness—Epirubicin—ovarian cancer	0.000246	0.00249	CcSEcCtD
Clofazimine—Somnolence—Paclitaxel—ovarian cancer	0.000244	0.00247	CcSEcCtD
Clofazimine—Nausea—Vinorelbine—ovarian cancer	0.000242	0.00245	CcSEcCtD
Clofazimine—Jaundice—Epirubicin—ovarian cancer	0.00024	0.00242	CcSEcCtD
Clofazimine—Decreased appetite—Paclitaxel—ovarian cancer	0.000239	0.00241	CcSEcCtD
Clofazimine—Fatigue—Paclitaxel—ovarian cancer	0.000237	0.00239	CcSEcCtD
Clofazimine—Constipation—Paclitaxel—ovarian cancer	0.000235	0.00237	CcSEcCtD
Clofazimine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000233	0.00236	CcSEcCtD
Clofazimine—Oedema—Docetaxel—ovarian cancer	0.000233	0.00235	CcSEcCtD
Clofazimine—Weight decreased—Doxorubicin—ovarian cancer	0.000231	0.00234	CcSEcCtD
Clofazimine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00023	0.00233	CcSEcCtD
Clofazimine—Drowsiness—Doxorubicin—ovarian cancer	0.000228	0.0023	CcSEcCtD
Clofazimine—Jaundice—Doxorubicin—ovarian cancer	0.000222	0.00224	CcSEcCtD
Clofazimine—Anorexia—Docetaxel—ovarian cancer	0.000222	0.00224	CcSEcCtD
Clofazimine—Hepatitis—Epirubicin—ovarian cancer	0.000221	0.00223	CcSEcCtD
Clofazimine—Body temperature increased—Paclitaxel—ovarian cancer	0.000217	0.00219	CcSEcCtD
Clofazimine—Visual impairment—Epirubicin—ovarian cancer	0.000213	0.00215	CcSEcCtD
Clofazimine—Somnolence—Docetaxel—ovarian cancer	0.000207	0.00209	CcSEcCtD
Clofazimine—Hepatitis—Doxorubicin—ovarian cancer	0.000204	0.00207	CcSEcCtD
Clofazimine—Decreased appetite—Docetaxel—ovarian cancer	0.000202	0.00204	CcSEcCtD
Clofazimine—Fatigue—Docetaxel—ovarian cancer	0.000201	0.00203	CcSEcCtD
Clofazimine—Constipation—Docetaxel—ovarian cancer	0.000199	0.00201	CcSEcCtD
Clofazimine—Visual impairment—Doxorubicin—ovarian cancer	0.000197	0.00199	CcSEcCtD
Clofazimine—Asthenia—Paclitaxel—ovarian cancer	0.000197	0.00199	CcSEcCtD
Clofazimine—Pruritus—Paclitaxel—ovarian cancer	0.000194	0.00196	CcSEcCtD
Clofazimine—Diarrhoea—Paclitaxel—ovarian cancer	0.000188	0.0019	CcSEcCtD
Clofazimine—Body temperature increased—Docetaxel—ovarian cancer	0.000184	0.00186	CcSEcCtD
Clofazimine—Dizziness—Paclitaxel—ovarian cancer	0.000181	0.00184	CcSEcCtD
Clofazimine—Anaemia—Epirubicin—ovarian cancer	0.000178	0.0018	CcSEcCtD
Clofazimine—Vomiting—Paclitaxel—ovarian cancer	0.000174	0.00176	CcSEcCtD
Clofazimine—Rash—Paclitaxel—ovarian cancer	0.000173	0.00175	CcSEcCtD
Clofazimine—Dermatitis—Paclitaxel—ovarian cancer	0.000173	0.00175	CcSEcCtD
Clofazimine—Headache—Paclitaxel—ovarian cancer	0.000172	0.00174	CcSEcCtD
Clofazimine—Asthenia—Docetaxel—ovarian cancer	0.000167	0.00169	CcSEcCtD
Clofazimine—Pruritus—Docetaxel—ovarian cancer	0.000165	0.00166	CcSEcCtD
Clofazimine—Anaemia—Doxorubicin—ovarian cancer	0.000164	0.00166	CcSEcCtD
Clofazimine—Nausea—Paclitaxel—ovarian cancer	0.000163	0.00165	CcSEcCtD
Clofazimine—Diarrhoea—Docetaxel—ovarian cancer	0.000159	0.00161	CcSEcCtD
Clofazimine—Oedema—Epirubicin—ovarian cancer	0.000157	0.00159	CcSEcCtD
Clofazimine—Dizziness—Docetaxel—ovarian cancer	0.000154	0.00156	CcSEcCtD
Clofazimine—Anorexia—Epirubicin—ovarian cancer	0.00015	0.00151	CcSEcCtD
Clofazimine—Vomiting—Docetaxel—ovarian cancer	0.000148	0.0015	CcSEcCtD
Clofazimine—Rash—Docetaxel—ovarian cancer	0.000147	0.00148	CcSEcCtD
Clofazimine—Dermatitis—Docetaxel—ovarian cancer	0.000147	0.00148	CcSEcCtD
Clofazimine—Headache—Docetaxel—ovarian cancer	0.000146	0.00147	CcSEcCtD
Clofazimine—Oedema—Doxorubicin—ovarian cancer	0.000145	0.00147	CcSEcCtD
Clofazimine—Somnolence—Epirubicin—ovarian cancer	0.000139	0.00141	CcSEcCtD
Clofazimine—Anorexia—Doxorubicin—ovarian cancer	0.000138	0.0014	CcSEcCtD
Clofazimine—Nausea—Docetaxel—ovarian cancer	0.000138	0.0014	CcSEcCtD
Clofazimine—Decreased appetite—Epirubicin—ovarian cancer	0.000136	0.00138	CcSEcCtD
Clofazimine—Fatigue—Epirubicin—ovarian cancer	0.000135	0.00137	CcSEcCtD
Clofazimine—Constipation—Epirubicin—ovarian cancer	0.000134	0.00136	CcSEcCtD
Clofazimine—Somnolence—Doxorubicin—ovarian cancer	0.000129	0.00131	CcSEcCtD
Clofazimine—Decreased appetite—Doxorubicin—ovarian cancer	0.000126	0.00128	CcSEcCtD
Clofazimine—Fatigue—Doxorubicin—ovarian cancer	0.000125	0.00127	CcSEcCtD
Clofazimine—Constipation—Doxorubicin—ovarian cancer	0.000124	0.00126	CcSEcCtD
Clofazimine—Body temperature increased—Epirubicin—ovarian cancer	0.000124	0.00125	CcSEcCtD
Clofazimine—Body temperature increased—Doxorubicin—ovarian cancer	0.000115	0.00116	CcSEcCtD
Clofazimine—Asthenia—Epirubicin—ovarian cancer	0.000113	0.00114	CcSEcCtD
Clofazimine—Pruritus—Epirubicin—ovarian cancer	0.000111	0.00112	CcSEcCtD
Clofazimine—Diarrhoea—Epirubicin—ovarian cancer	0.000107	0.00109	CcSEcCtD
Clofazimine—Asthenia—Doxorubicin—ovarian cancer	0.000104	0.00105	CcSEcCtD
Clofazimine—Dizziness—Epirubicin—ovarian cancer	0.000104	0.00105	CcSEcCtD
Clofazimine—Pruritus—Doxorubicin—ovarian cancer	0.000103	0.00104	CcSEcCtD
Clofazimine—Vomiting—Epirubicin—ovarian cancer	9.98e-05	0.00101	CcSEcCtD
Clofazimine—Diarrhoea—Doxorubicin—ovarian cancer	9.93e-05	0.001	CcSEcCtD
Clofazimine—Rash—Epirubicin—ovarian cancer	9.89e-05	0.001	CcSEcCtD
Clofazimine—Dermatitis—Epirubicin—ovarian cancer	9.88e-05	0.000999	CcSEcCtD
Clofazimine—Headache—Epirubicin—ovarian cancer	9.83e-05	0.000994	CcSEcCtD
Clofazimine—Dizziness—Doxorubicin—ovarian cancer	9.6e-05	0.000971	CcSEcCtD
Clofazimine—Nausea—Epirubicin—ovarian cancer	9.32e-05	0.000942	CcSEcCtD
Clofazimine—Vomiting—Doxorubicin—ovarian cancer	9.23e-05	0.000933	CcSEcCtD
Clofazimine—Rash—Doxorubicin—ovarian cancer	9.15e-05	0.000926	CcSEcCtD
Clofazimine—Dermatitis—Doxorubicin—ovarian cancer	9.14e-05	0.000925	CcSEcCtD
Clofazimine—Headache—Doxorubicin—ovarian cancer	9.09e-05	0.00092	CcSEcCtD
Clofazimine—Nausea—Doxorubicin—ovarian cancer	8.62e-05	0.000872	CcSEcCtD
